首页> 外文会议>Proceedings of the First regional conference IEEE Engineering in Medicine amp; Biology Society and 14th conference of the Biomedical Engineering Society of India >Role of Laser Therapy in Management of Treatment Failure Cases of Pulmonary Tuberculosis as an Adjuvent to Chemotherapy
【24h】

Role of Laser Therapy in Management of Treatment Failure Cases of Pulmonary Tuberculosis as an Adjuvent to Chemotherapy

机译:激光疗法在治疗肺结核作为化学疗法的辅助治疗失败病例中的作用

获取原文
获取原文并翻译 | 示例

摘要

Pulmonary Tuberculosis is number one public health problem our Country. About half of our population is infected by it. The total number of Tuberculosis patients in India constitute half of world's tuberculosis cases. With such seriousness of the problem of tuberculosis is it possible for India to attain the target of WHO to achieve health for all by 2000 A.D. and see the diapperance or control of tuberculosis ? The causes of this aggravating problem of tuberculosis are many. Some of the most important are poor cure rate, low case finding, hightreatment default, high bacterial resistance, etc. WHO has given priority to increase the cure rate. Field studies in our Country have shown that cure rate with standard regimen is not more than 35 percent, whereas WHO has recommended a target of 35 percent for developing countries like India. To achieve this big gap our Institute has entered into an agreement with Uzbek scientist through Department of Science and Technology (DST), Ministry of Science and Technology, Government of India to set up an Uzbek joint medical Centre for Laser treatment.
机译:肺结核是我国的第一大公共卫生问题。我们人口中约有一半被其感染。印度的结核病患者总数占世界结核病病例的一半。鉴于结核病问题如此严重,印度是否有可能实现世界卫生组织的目标,即到公元2000年实现全民健康并看到结核病的扩散或控制?导致结核病恶化的原因很多。最重要的一些因素是治愈率低,发现病例少,治疗失误高,细菌耐药性高等。WHO已将提高治愈率作为优先事项。我国的现场研究表明,标准疗法的治愈率不超过35%,而世界卫生组织建议印度等发展中国家的目标是35%。为了实现这一巨大差距,我们研究所已通过印度政府科学技术部科学技术部(DST)与乌兹别克斯坦科学家达成了一项协议,以建立乌兹别克斯坦联合激光治疗医学中心。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号